Turning Point Therapeutics, Inc.

MORGAN STANLEY

Report date

6/30/2022

Quarter

2022 Q2

Filed

10/27/2022

Shares

670,522

Value ($000)

50,457

Weight

0.0%

2019 Q4 - 2022 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	10/27/2022	50,457	0.0%	670,522	6/30/2022
2022 Q1	10/27/2022	15,421	0.0%	574,372	3/31/2022
2021 Q4	2/14/2022	16,110	0.0%	337,760	12/31/2021
2021 Q3	11/15/2021	2,685	0.0%	40,403	9/30/2021
2021 Q2	8/23/2021	4,204	0.0%	53,882	6/30/2021
2021 Q1	5/17/2021	660	0.0%	6,973	3/31/2021
2020 Q4	2/16/2021	6,219	0.0%	51,038	12/31/2020
2020 Q3	11/13/2020	827	0.0%	9,467	9/30/2020
2020 Q2	8/14/2020	853	0.0%	13,210	6/30/2020
2020 Q1	5/26/2020	147	0.0%	3,288	3/31/2020
2019 Q4	2/14/2020	2,409	0.0%	38,678	12/31/2019